ZVSA
ZyVersa Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.10
−0.20%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-50.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 16, 2025 | Cashmere Karen A. · officer: Chief Commercial Officer | A-Award | 48,100 | $0.59 |
| Jul 15, 2025 | Freitag Gregory Gene · director | A-Award | 11,066 | $0.59 |
| Jul 15, 2025 | Glover Stephen C. · director, officer: Chief Executive Officer | A-Award | 136,900 | $0.59 |
| Jul 15, 2025 | Finizio Robert G · director | A-Award | 11,066 | $0.59 |
| Jul 15, 2025 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 60,100 | $0.59 |
| Jul 15, 2025 | Guzman Pablo A. · officer: Chief Medical Officer | A-Award | 48,900 | $0.59 |
| Jul 15, 2025 | Park Min-Chul · director | A-Award | 11,066 | $0.59 |
| Jul 15, 2025 | SAPIRSTEIN JAMES · director | A-Award | 11,066 | $0.59 |
| Jul 18, 2024 | Cashmere Karen A. · director | A-Award | 572 | $152 |
| Jul 18, 2024 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 715 | $152 |
| Jul 18, 2024 | Glover Stephen C. · director, officer: Chief Executive Officer | A-Award | 1,627 | $152 |
| Jul 18, 2024 | Park Min-Chul · director | A-Award | 132 | $152 |
| Jul 18, 2024 | Freitag Gregory Gene · director | A-Award | 132 | $152 |
| Jul 18, 2024 | SAPIRSTEIN JAMES · director | A-Award | 132 | $152 |
| Jul 18, 2024 | Finizio Robert G · director | A-Award | 132 | $152 |
| Jan 26, 2023 | Guzman Pablo A. · officer: Chief Medical Officer | A-Award | 100,000 | $0.00 |
| Dec 20, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 3,000 | $2.88 |
| Dec 16, 2022 | INCON Co., Ltd. · director | A-Award | 1,497,199 | $0.00 |
| Dec 16, 2022 | INCON Co., Ltd. · director | A-Award | 450,702 | $0.00 |
| Dec 14, 2022 | Finizio Robert G · director | A-Award | 29,781 | $0.00 |
| Dec 14, 2022 | Finizio Robert G · director | A-Award | 19,854 | $0.00 |
| Dec 14, 2022 | Finizio Robert G · director | A-Award | 9,927 | $0.00 |
| Dec 14, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 41,585 | $0.00 |
| Dec 14, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 39,708 | $0.00 |
| Dec 14, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 21,840 | $0.00 |
| Dec 14, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 18,058 | $0.00 |
| Dec 14, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 11,763 | $0.00 |
| Dec 14, 2022 | Wolfe Peter · officer: Chief Financial Officer | A-Award | 9,927 | $0.00 |
| Dec 14, 2022 | Park Min-Chul · director | A-Award | 29,781 | $0.00 |
| Dec 14, 2022 | Park Min-Chul · director | A-Award | 9,927 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 16, 2025